
  
    
      
        Background_NNP
        The_DT G_NNP protein-coupled_JJ receptors_NNS constitute_VBP a_DT large_JJ
        family_NN of_IN receptors_NNS widely_RB distributed_VBN in_IN the_DT mammalian_JJ
        central_JJ nervous_JJ system_NN (_( CNS_NNP )_) ._. Classical_NNP neurotransmitter_NN
        receptors_NNS such_JJ as_IN muscarinic_JJ acetylcholine_NN receptors_NNS
        (_( mAChR_NN )_) ,_, adrenergic_JJ ,_, dopaminergic_JJ ,_, serotoninergic_JJ as_IN well_RB
        as_IN neuropeptide_NN receptors_NNS belong_VBP to_TO this_DT family_NN (_( 1_LS )_) ._. 
        In_IN vitro_NN studies_NNS in_IN transfected_JJ cells_NNS
        show_VBP that_IN following_VBG receptor_NN activation_NN by_IN an_DT agonist_NN that_WDT
        induces_VBZ signal_NN transduction_NN ,_, G_NNP protein-coupled_JJ receptor_NN
        undergoes_NNS phosphorylation_NN ,_, endocytosis_NNS ,_, and_CC dissociation_NN
        from_IN their_PRP$ ligand_NN in_IN the_DT endosome_NN ,_, and_CC finally_RB the_DT
        receptors_NNS are_VBP recycled_VBN to_TO the_DT plasma_NN membrane_NN (_( 2_CD ,_, 3_CD ,_, 4_LS )_) ._.
        The_DT delta_NN (_( δ_NN )_) -_: opioid_NN receptor_NN is_VBZ a_DT member_NN of_IN the_DT seven_CD
        transmembrane_NN superfamily_RB of_IN G-_NNP protein_NN coupled_VBN receptors_NNS (_(
        5_CD ,_, 6_CD )_) ._. 
        In_IN vitro_NN studies_NNS ,_, carried_VBD out_IN on_IN
        NG_NNP 108_CD -_: 15_CD neurohybrid_NN cells_NNS which_WDT express_VBP large_JJ numbers_NNS of_IN
        δ-opioid_JJ receptors_NNS ,_, show_NN that_IN these_DT receptors_NNS undergo_VBP a_DT
        rapid_JJ agonist-induced_JJ desensitization_NN that_WDT occurs_VBZ within_IN
        minutes_NNS and_CC down-regulation_JJ that_WDT occurs_VBZ more_RBR slowly_RB over_IN
        several_JJ hours_NNS (_( 4_CD ,_, 7_CD )_) ._. The_DT internalization_NN of_IN
        receptor-agonist_JJ ligand_NN complex_NN has_VBZ been_VBN detected_VBN with_IN
        similar_JJ kinetics_NNS to_TO those_DT of_IN down-regulation_JJ (_( 8_CD ,_, 9_CD )_) ._. These_DT
        findings_NNS raise_VBP two_CD related_VBN questions_NNS :_: 1_LS )_) can_MD δ-opioid_JJ
        receptors_NNS be_VB internalized_JJ 
        in_IN vivo_NN by_IN the_DT same_JJ agonist-induced_JJ
        endocytosis_NNS observed_VBD 
        in_IN vitro_NN ?_. and_CC if_IN this_DT is_VBZ the_DT case_NN ,_,
        2_LS )_) does_VBZ the_DT internalization_NN process_NN have_VBP the_DT same_JJ kinetics_NNS
        reported_VBD from_IN 
        in_IN vitro_NN studies_NNS ?_.
        We_PRP examined_VBD the_DT effect_NN of_IN dermenkephalin_NN ,_, a_DT specific_JJ
        δ-opioid_JJ agonist_NN ,_, in_IN order_NN to_TO mimic_VB the_DT effect_NN of_IN a_DT strong_JJ
        and_CC constant_JJ activation_NN by_IN an_DT agonist_NN ,_, on_IN the_DT distribution_NN
        of_IN the_DT δ-opioid_JJ receptors_NNS ,_, in_IN the_DT dorsal_NN horn_NN of_IN the_DT rat_NN
        spinal_JJ cord_NN ._. We_PRP used_VBD a_DT monoclonal_NN anti-idiotypic_JJ antibody_NN
        (_( anti-_NN Id_NN mAb_NN )_) raised_VBD against_IN the_DT δ-opioid_JJ receptors_NNS (_( 10_CD )_) ,_,
        and_CC detected_VBN by_IN electron_NN microscopic_JJ immunocytochemistry_NN ._.
        In_IN the_DT present_JJ work_NN ,_, we_PRP demonstrate_VBP that_IN δ-opioid_JJ receptor_NN
        undergo_VBP rapid_JJ agonist-induced_JJ endocytosis_NNS in_IN the_DT CNS_NNP ._.
      
      
        Results_NNS
        Light_NN microscopy_NN revealed_VBD that_IN the_DT regional_JJ distribution_NN
        of_IN anti-_NN Id_NN mAb_NN immunoreactivity_NN in_IN control_NN rats_NNS receiving_VBG
        saline_NN solution_NN ,_, was_VBD comparable_JJ to_TO previous_JJ studies_NNS using_VBG
        unoperated_JJ rats_NNS (_( 10_CD ,_, 11_CD ,_, 12_CD ,_, 13_CD )_) ._. A_DT high_JJ concentration_NN of_IN
        immunoreactivity_NN was_VBD localized_JJ in_IN the_DT superficial_JJ layers_NNS of_IN
        the_DT dorsal_NN horn_NN (_( Fig_NNP ._. 1_LS a_DT )_) ._. In_IN addition_NN ,_, labelling_VBG was_VBD found_VBN
        around_IN the_DT central_JJ canal_NN (_( layer_NN X_NNP )_) (_( Fig_NNP ._. 1_LS b_SYM )_) ,_, and_CC in_IN the_DT
        ventral_NN horn_NN ._. Ultrastructural_NNP study_NN of_IN lamina_NN I_PRP and_CC II_NNP
        showed_VBD that_DT immunoreactivity_NN was_VBD mainly_RB localized_JJ at_IN
        appositions_NNS between_IN two_CD neurites_NNS ;_: axo-dendritic_JJ (_( Fig_NNP ._. 2_LS a_DT )_)
        and_CC axo-axonic_JJ appositions_NNS (_( Fig_NNP ._. 2_LS b_SYM )_) were_VBD noted_VBN ._. Some_DT
        neurites_NNS displayed_VBD multiple_JJ labelling_VBG sites_NNS at_IN appositions_NNS
        with_IN dendrite_NN and_CC /_NN or_CC axon_NN as_IN shown_VBN in_IN Fig_NNP ._. 3_LS ._. We_PRP never_RB
        observed_VBD staining_VBG directly_RB at_IN the_DT level_NN of_IN a_DT synaptic_JJ
        differentiation_NN ._. However_RB ,_, synaptic_JJ differentiations_NNS were_VBD
        occasionally_RB near_IN or_CC in_IN continuity_NN with_IN sites_NNS of_IN
        axo-dendritic_JJ labelling_VBG (_( Fig_NNP ._. 2_LS a_DT )_) ._. Occasionally_RB the_DT
        labelling_VBG was_VBD at_IN the_DT interface_NN between_IN a_DT neurite_NN and_CC a_DT
        glial_NN process_NN in_IN laminae_NN I_PRP and_CC II_NNP of_IN the_DT spinal_JJ cord_NN ._. In_IN
        all_DT cases_NNS ,_, it_PRP was_VBD not_RB possible_JJ to_TO associate_JJ the_DT membrane_NN
        labelling_VBG with_IN one_CD or_CC the_DT other_JJ profile_NN due_JJ to_TO the_DT
        localization_NN of_IN the_DT labelling_VBG strictly_RB in_IN the_DT extracellular_NN
        space_NN ._. A_DT few_JJ intracellular_NN labellings_NNS were_VBD also_RB found_VBN ,_,
        mainly_RB associated_VBN with_IN rough_JJ endoplasmic_JJ reticulum_NN (_( RER_NNP )_)
        and_CC Golgi_NNP apparatus_NN in_IN the_DT soma_NN of_IN labelled_JJ cells_NNS (_( not_RB
        shown_VBN ;_: see_VB 12_CD )_) ._.
        For_IN rats_NNS receiving_VBG the_DT cocktail_NN of_IN peptidase_NN inhibitors_NNS ,_,
        at_IN the_DT ultrastructural_NN level_NN we_PRP observed_VBD a_DT pattern_NN of_IN
        labelling_VBG comparable_JJ to_TO that_DT described_VBD in_IN rats_NNS receiving_VBG a_DT
        saline_NN solution_NN (_( not_RB shown_VBN )_) ._. No_DT visible_JJ redistribution_NN of_IN
        anti-id_JJ mAb_NN immunoreactivity_NN was_VBD observed_VBN in_IN response_NN to_TO
        kelatorphan_NN and_CC thiorphan_NN ._.
        Fifteen_CD minutes_NNS after_IN dermenkephalin_NN administration_NN ,_, the_DT
        ultrastructural_NN analysis_NN showed_VBD a_DT pattern_NN of_IN labelling_VBG
        quite_RB different_JJ from_IN that_DT observed_VBD in_IN the_DT control_NN rats_NNS in_IN
        lamina_NN I_PRP ._. At_IN the_DT level_NN of_IN labelling_VBG ,_, the_DT plasma_NN membrane_NN
        was_VBD noticeably_RB invaginated_JJ (_( Fig_NNP ._. 4_LS a_DT and_NN b_SYM )_) ._. Most_JJS of_IN the_DT
        labelling_VBG was_VBD associated_VBN with_IN axon_NN terminals_NNS (_( Fig_NNP ._. 4_LS a_DT )_) ._.
        Dendritic_NNP labelling_VBG was_VBD also_RB found_VBN (_( Fig_NNP ._. 4_LS b_SYM )_) but_CC was_VBD less_RBR
        abundant_JJ ._. The_DT rest_NN of_IN the_DT labelling_VBG was_VBD associated_VBN with_IN
        unidentifiable_JJ profiles_NNS ._. In_IN lamina_NN II_NNP ,_, labelling_VBG was_VBD
        associated_VBN with_IN both_DT invaginated_JJ and_CC flat_JJ plasma_NN
        membrane_NN ._.
        In_IN sections_NNS from_IN the_DT four_CD animals_NNS studied_VBN after_IN 30_CD
        minutes_NNS of_IN stimulation_NN ,_, immunoreactivity_NN was_VBD observed_VBN
        intracellularly_RB ._. In_IN lamina_NN I_PRP ,_, large_JJ vesicles_NNS (_( 120_CD nm-_NN 150_CD
        nm_NN )_) were_VBD labelled_JJ in_IN the_DT cytoplasm_NN close_RB to_TO the_DT plasma_NN
        membrane_NN (_( Fig_NNP ._. 4_LS c_SYM )_) ._. Labelled_NNP microtubules_NNS were_VBD also_RB found_VBN
        (_( Fig_NNP ._. 4_LS d_SYM )_) ._. No_DT extracellular_NN labelling_VBG associated_VBN with_IN the_DT
        plasma_NN membrane_NN was_VBD found_VBN in_IN this_DT lamina_NN ._. In_IN lamina_NN II_NNP ,_,
        cytoplasmic_JJ labellings_NNS (_( mainly_RB labelled_JJ vesicles_NNS )_) as_RB well_RB
        as_IN membrane_NN labellings_NNS not_RB restricted_VBN to_TO the_DT invaginated_JJ
        area_NN ,_, were_VBD found_VBN ._.
      
      
        Discussion_NNP
        In_IN this_DT study_NN ,_, we_PRP provide_VBP morphological_JJ evidence_NN that_IN
        δ-opioid_JJ receptors_NNS are_VBP endocytosed_JJ in_IN response_NN to_TO
        dermenkephalin_NN 
        in_IN vivo_NN ._. The_DT choice_NN of_IN
        dermenkephalin_NN as_IN agonist_NN in_IN this_DT study_NN was_VBD determined_VBN by_IN
        the_DT intrinsic_JJ quality_NN of_IN this_DT ligand_NN ._. Isolated_NNP from_IN the_DT
        skin_NN of_IN the_DT frog_NN 
        Phyllomedusa_NNP sauvagei_NN (_( 14_CD )_) ,_, this_DT
        natural_JJ peptide_NN shows_VBZ the_DT highest_JJS affinity_NN for_IN the_DT δ-opioid_JJ
        receptor_NN (_( 0_CD ._. 47_CD nM_NN )_) and_CC a_DT selectivity_NN of_IN 4_CD ,_, 000_CD -_: fold_VB greater_JJR
        for_IN the_DT δ-_NN than_IN the_DT μ-opioid_JJ receptors_NNS ,_, even_RB when_WRB compared_VBN
        to_TO the_DT other_JJ very_RB potent_JJ deltorphin_NN I_PRP (_( isolated_VBN from_IN the_DT
        frog_NN 
        Phyllomedusa_NNP bicolor_NN ,_, 15_CD )_) which_WDT has_VBZ
        an_DT affinity_NN of_IN 0_CD ._. 60_CD nM_NN and_CC a_DT selectivity_NN of_IN 3_CD ,_, 570_CD fold_VB
        greater_JJR δ_NN /_NN μ_NN ._. Both_DT peptides_NNS ,_, along_IN with_IN the_DT dermorphin_NN and_CC
        the_DT deltorphin_NN II_NNP also_RB isolated_VBD from_IN amphibian_NN skin_NN ,_,
        possess_VBP an_DT unique_JJ feature_NN among_IN peptides_NNS synthesized_JJ by_IN
        animal_NN cells_NNS in_IN having_VBG a_DT D-_NNP amino_JJ acid_NN residue_NN ,_, providing_VBG a_DT
        very_RB strong_JJ resistance_NN to_TO enzymatic_JJ degradation_NN to_TO these_DT
        ligands_NNS ._. Considering_VBG our_PRP$ experimental_JJ conditions_NNS ,_,
        particularly_RB using_VBG a_DT single_NN 
        in_IN vivo_NN injection_NN ,_, the_DT dermenkephalin_NN
        seemed_VBD the_DT most_RBS suitable_JJ agonist_NN ligand_NN to_TO specifically_RB
        stimulate_VB the_DT δ-opioid_JJ receptor_NN and_CC provoke_VB a_DT possible_JJ
        internalization_NN of_IN the_DT receptor_NN due_JJ to_TO its_PRP$ affinity_NN as_RB well_RB
        as_IN to_TO its_PRP$ strong_JJ resistance_NN to_TO degradation_NN ._.
        The_DT selectivity_NN of_IN the_DT rat_NN monoclonal_NN anti-idiotypic_JJ
        antibody_NN used_VBN as_IN primary_JJ antibody_NN to_TO recognize_VB the_DT δ-opioid_JJ
        receptor_NN (_( anti-_NN Id_NN mAb_NN )_) in_IN the_DT present_JJ report_NN has_VBZ been_VBN
        thoroughly_RB investigated_VBN in_IN previous_JJ studies_NNS (_( 10_CD ,_, 12_CD ,_, 13_CD )_) ._.
        First_LS ,_, the_DT anti-_NN Id_NN mAb_NN raised_VBD against_IN an_DT anti_NN DADLE_NNP (_( 10_CD ,_,
        11_CD )_) totally_RB inhibited_VBD the_DT δ-agonist_JJ ligand_NN /_NN anti-ligand_JJ
        interaction_NN ,_, showing_VBG a_DT good_JJ anti-idiotypic_JJ activity_NN ._.
        Second_JJ ,_, it_PRP was_VBD able_JJ to_TO label_VB the_DT δ-opioid_JJ receptor_NN
        expressed_VBN by_IN the_DT NG_NNP 108_CD -_: 15_CD cell_NN line_NN and_CC inhibited_VBD 3_CD H-DADLE_NNP
        binding_VBG to_TO this_DT same_JJ cell_NN line_NN ._. The_DT anti-_NN Id_NN mAb_NN was_VBD also_RB
        able_JJ to_TO precipitate_NN a_DT 52_CD ,_, 500_CD Da_NNP molecule_NN in_IN the_DT NG_NNP 108_CD -_: 15_CD
        cells_NNS ._. Third_NNP ,_, in_IN rat_NN spinal_JJ cord_NN (_( 12_CD )_) ,_, we_PRP found_VBD that_DT
        preincubation_NN of_IN fixed_VBN tissue_NN with_IN specific_JJ δ-opioid_JJ
        ligands_NNS (_( DADLE_NNP ,_, Met-enkephalin_NNP ,_, dermenkephalin_NN and_CC
        naltrindole_NN at_IN 10_CD -_: 9_CD M_NNP )_) totally_RB prevented_VBD the_DT antibody_NN
        labeling_VBG ,_, showing_VBG a_DT good_JJ competition_NN between_IN ligands_NNS and_CC
        the_DT anti-_NN Id_NN mAb_NN ._. Fourth_JJ ,_, we_PRP also_RB found_VBD previously_RB in_IN rat_NN
        spinal_JJ cord_NN that_DT anti-_NN Id_NN mAb_NN has_VBZ an_DT hundred-fold_JJ greater_JJR
        affinity_NN for_IN δ-opioid_JJ receptors_NNS than_IN μ-opioid_JJ receptors_NNS (_(
        12_CD )_) ._. Taken_VBN together_RB ,_, these_DT data_NNS show_VBP that_DT anti-_NN Id_NN mAb_NN is_VBZ a_DT
        reliable_JJ tool_NN to_TO specifically_RB detect_VB the_DT δ-opioid_JJ receptor_NN
        using_VBG immunocytochemical_JJ techniques_NNS ._.
        In_IN the_DT present_JJ study_NN ,_, we_PRP found_VBD in_IN our_PRP$ control_NN group_NN the_DT
        same_JJ pattern_NN of_IN labelling_VBG seen_VBN by_IN earlier_JJR studies_NNS in_IN
        unoperated_JJ rats_NNS (_( 10_CD ,_, 11_CD ,_, 12_CD )_) suggesting_VBG that_DT saline_NN
        injection_NN ,_, at_IN the_DT level_NN of_IN the_DT spinal_JJ cord_NN ,_, does_VBZ not_RB
        provoke_VB a_DT visible_JJ redistribution_NN of_IN the_DT δ-opioid_JJ sites_NNS at_IN
        the_DT plasma_NN membrane_NN ._. No_DT labelling_VBG associated_VBN with_IN an_DT
        invaginated_JJ plasma_NN membrane_NN was_VBD found_VBN in_IN our_PRP$ experimental_JJ
        control_NN rats_NNS ._.
        In_IN rats_NNS receiving_VBG the_DT cocktail_NN of_IN peptidase_NN inhibitor_NN
        (_( i_NNP ._. e_SYM ._. without_IN dermenkephalin_NN )_) ,_, no_DT modification_NN of_IN the_DT
        δ-opioid_JJ receptor_NN distribution_NN was_VBD noted_VBN compared_VBN with_IN our_PRP$
        control_NN rats_NNS (_( receiving_VBG only_RB NaCl_NNP )_) ._. A_DT previous_JJ study_NN showed_VBD
        that_DT kelatorphan_NN in_IN addition_NN to_TO blocking_VBG the_DT degradation_NN of_IN
        the_DT exogenous_JJ peptide_NN by_IN suppressing_VBG the_DT aminopeptidase_NN
        activity_NN ,_, markedly_RB increased_VBD the_DT spontaneous_JJ release_NN of_IN
        endogenous_JJ Met-enkephalin_NNP 
        in_IN vivo_NN and_CC 
        in_IN vitro_NN (_( 16_CD )_) ._. Thiorphan_NNP is_VBZ a_DT potent_JJ
        enkephalinase_NN inhibitor_NN (_( 17_CD )_) ._. Nevertheless_RB ,_, it_PRP seems_VBZ that_IN
        under_IN our_PRP$ experimental_JJ conditions_NNS ,_, even_RB if_IN more_JJR enkephalin_NN
        was_VBD released_VBN by_IN the_DT kelatorphan_NN ,_, and_CC this_DT enkephalin_NN was_VBD
        selectively_RB protected_VBN from_IN degradation_NN by_IN thiorphan_NN ,_, no_DT
        receptor_NN endocytosis_NNS was_VBD observed_VBN in_IN response_NN to_TO endogenous_JJ
        enkephalin_NN ._. However_RB ,_, no_DT nociceptive_JJ stimulation_NN was_VBD applied_VBN
        in_IN our_PRP$ protocol_NN ,_, and_CC we_PRP therefore_RB can_MD not_RB exclude_VB the_DT
        possibility_NN that_IN insufficient_JJ enkephalin_NN was_VBD released_VBN to_TO
        provoke_VB the_DT internalization_NN of_IN the_DT δ-opioid_JJ receptor_NN ._.
        Another_DT hypothesis_NNS poses_VBZ the_DT question_NN of_IN whether_IN the_DT
        internalization_NN process_NN is_VBZ agonist-selective_JJ ._. In_IN a_DT study_NN
        carried_VBD out_IN 
        in_IN vivo_NN on_IN guinea_NN pig_NN ileum_NN (_( 18_CD )_) ,_,
        the_DT authors_NNS showed_VBD a_DT rapid_JJ endocytosis_NNS of_IN the_DT μ-opioid_JJ
        receptor_NN in_IN neurons_NNS in_IN response_NN to_TO etorphine_NN stimulation_NN
        but_CC not_RB after_IN morphine_NN administration_NN ._. This_DT shows_VBZ that_IN
        using_VBG a_DT high-affinity_JJ agonist_NN such_JJ as_IN morphine_NN ,_, it_PRP is_VBZ not_RB
        possible_JJ to_TO trigger_VB the_DT endocytosis_NNS process_VBP ._. The_DT authors_NNS
        suggest_VBP that_DT morphine_NN has_VBZ low_JJ intrinsic_JJ activity_NN at_IN
        μ-opioid_JJ receptor_NN compared_VBN for_IN instance_NN to_TO the_DT lower_JJR
        affinity_NN μ_NN agonist_NN [_NN D-A_NNP la_FW 2_CD ,_, N-M_NNP ePhe_NN 4_CD ,_, Gly_NNP 5_CD -_: ol_NN ]_NN enkephaline_NN
        (_( DAMGO_NNP )_) which_WDT is_VBZ able_JJ to_TO trigger_VB an_DT internalization_NN
        process_NN ._. This_DT differential_NN agonist-selective_JJ response_NN for_IN
        the_DT same_JJ receptor_NN could_MD participate_VB in_IN mechanisms_NNS
        regulating_VBG cellular_JJ adaptation_NN to_TO ligands_NNS ._. We_PRP do_VBP not_RB know_VB
        if_IN endogenous_JJ enkephalins_NNS are_VBP able_JJ to_TO induce_VB the_DT
        endocytosis_NNS of_IN δ-opioid_JJ receptors_NNS 
        in_IN vivo_NN ._. A_DT recent_JJ study_NN carried_VBD out_IN
        on_IN organotypic_JJ cultures_NNS and_CC neuromuscular_NN preparations_NNS ,_,
        demonstrated_VBD a_DT possible_JJ internalization_NN process_NN of_IN μ-opioid_JJ
        receptor_NN by_IN endogenously_RB released_VBN enkephalins_NNS after_IN
        electrical_JJ stimulation_NN (_( 19_CD )_) ._. Our_PRP$ data_NNS presented_VBN here_RB show_NN
        clearly_RB that_IN without_IN any_DT kind_NN of_IN stimulation_NN the_DT
        endogenously_RB released_VBN enkephalins_NNS (_( even_RB protected_VBN by_IN
        enkephalinase_NN inhibitors_NNS )_) were_VBD not_RB able_JJ to_TO induced_VBD an_DT
        internalization_NN of_IN the_DT δ-opioid_JJ receptors_NNS in_IN the_DT rat_NN spinal_JJ
        cord_NN ._. Nevertheless_RB ,_, a_DT more_RBR specific_JJ study_NN should_MD be_VB
        conducted_VBN in_IN order_NN to_TO answer_VB this_DT question_NN ._.
        By_IN contrast_NN ,_, application_NN of_IN dermenkephalin_NN induced_VBD an_DT
        internalization_NN of_IN the_DT δ-opioid_JJ receptor_NN within_IN 30_CD minutes_NNS ._.
        Dermenkephalin_NNP is_VBZ markedly_RB increased_VBN in_IN potency_NN in_IN the_DT
        presence_NN of_IN peptidase_NN inhibition_NN -_: more_JJR than_IN one_CD hundred_CD
        fold_VB with_IN a_DT cocktail_NN of_IN bacitracin_NN ,_, bestatin_NN ,_, and_CC
        captopril-_NN as_IN in_IN Kramer_NNP 's_POS study_NN (_( 20_CD )_) ,_, and_CC to_TO a_DT greater_JJR
        extent_NN with_IN kelatorphan_NN and_CC thiorphan_NN as_IN used_VBN in_IN the_DT
        present_JJ study_NN ._. This_DT suggests_VBZ that_IN the_DT effect_NN observed_VBD after_IN
        dermenkephalin_NN application_NN ,_, associated_VBN with_IN the_DT peptidase_NN
        inhibition_NN ,_, is_VBZ probably_RB stronger_JJR than_IN the_DT potency_NN of_IN
        dermenkephalin_NN alone_RB ._. It_PRP seems_VBZ that_IN the_DT δ-opioid_JJ receptor_NN
        was_VBD internalized_JJ to_TO a_DT greater_JJR extent_NN in_IN the_DT lamina_NN I_PRP than_IN
        in_IN the_DT deeper_JJR layers_NNS ._. This_DT could_MD be_VB due_JJ to_TO a_DT gradient_NN of_IN
        diffusion_NN in_IN the_DT tissues_NNS of_IN dermenkephalin_NN ._.
        Our_PRP$ results_NNS show_VBP a_DT majority_NN of_IN labelling_VBG associated_VBN with_IN
        axons_NNS ,_, confirming_VBG the_DT reports_NNS that_IN δ-opioid_JJ receptors_NNS
        mainly_RB have_VBP a_DT presynaptic_JJ localization_NN in_IN the_DT dorsal_NN horn_NN
        of_IN the_DT rat_NN spinal_JJ cord_NN (_( 12_CD ,_, 21_CD ,_, 22_CD ,_, 23_CD )_) ._. On_IN the_DT other_JJ
        hand_NN ,_, association_NN of_IN labelling_VBG with_IN a_DT dendrite_NN is_VBZ
        consistent_JJ with_IN the_DT existence_NN of_IN a_DT postsynaptic_JJ δ-receptor_JJ
        population_NN in_IN lamina_NN I_PRP and_CC II_NNP ._. This_DT is_VBZ in_IN agreement_NN with_IN
        data_NNS obtained_VBN after_IN unilateral_JJ dorsal_NN rhizotomy_NN which_WDT
        showed_VBD residual_JJ and_CC presumably_RB postsynaptic_JJ δ_NN sites_NNS (_(
        21_CD )_) ._.
        We_PRP cannot_NN exclude_VBP the_DT possibility_NN that_IN labelled_JJ vesicles_NNS
        found_VBD in_IN the_DT cytoplasm_NN after_IN 30_CD minutes_NNS of_IN stimulation_NN ,_, may_MD
        correspond_VB to_TO receptors_NNS in_IN the_DT process_NN of_IN expression_NN to_TO the_DT
        plasma_NN membrane_NN ._. Studies_NNS using_VBG direct_JJ antibodies_NNS raised_VBD
        against_IN the_DT δ-opioid_JJ sites_NNS has_VBZ shown_VBN immunoreactivity_NN
        mostly_RB associated_VBN with_IN large_JJ dense_JJ core_NN vesicles_NNS in_IN the_DT
        normal_JJ rat_NN dorsal_NN horn_NN (_( 22_CD ,_, 23_CD )_) ._. Intracellular_NNP labelling_VBG
        was_VBD also_RB found_VBN in_IN our_PRP$ control_NN rats_NNS but_CC the_DT association_NN of_IN
        labelling_VBG was_VBD mainly_RB with_IN RER_NNP and_CC Golgi_NNP apparatus_NN in_IN soma_NN ,_,
        probably_RB corresponding_JJ to_TO receptors_NNS in_IN the_DT process_NN of_IN
        synthesis_NN or_CC recycling_NN ._. This_DT observation_NN confirms_VBZ findings_NNS
        described_VBN in_IN our_PRP$ recent_JJ study_NN where_WRB somatic_JJ labelling_VBG was_VBD
        detected_VBN (_( 13_CD )_) ._. Also_RB ,_, a_DT few_JJ labelled_JJ vesicles_NNS have_VBP been_VBN
        outlined_VBN in_IN our_PRP$ previous_JJ study_NN (_( 12_CD )_) ,_, but_CC the_DT frequency_NN of_IN
        this_DT association_NN was_VBD slight_JJ and_CC not_RB comparable_JJ with_IN those_DT
        described_VBN in_IN the_DT present_JJ study_NN after_IN stimulation_NN by_IN
        dermenkephalin_NN ._. The_DT differences_NNS found_VBD in_IN the_DT distribution_NN
        of_IN the_DT labelling_VBG (_( membrane_NN labelling_VBG versus_CC intracellular_NN
        labelling_VBG )_) between_IN our_PRP$ study_NN and_CC the_DT direct_JJ antibody_NN study_NN
        (_( 23_CD )_) may_MD be_VB due_JJ to_TO the_DT intrinsic_JJ characteristic_NN between_IN an_DT
        anti-idiotypic_JJ antibody_NN raised_VBD against_IN the_DT binding_JJ site_NN of_IN
        the_DT receptor_NN and_CC a_DT direct_JJ antibody_NN recognizing_VBG a_DT fragment_NN
        of_IN the_DT receptor_NN ._. Taken_VBN together_RB ,_, the_DT data_NNS suggest_VBP that_IN
        immunoreactive_JJ vesicles_NNS found_VBD in_IN our_PRP$ study_NN are_VBP the_DT result_NN
        of_IN an_DT internalization_NN of_IN the_DT δ-opioid_JJ receptors_NNS in_IN response_NN
        to_TO the_DT stimulation_NN by_IN dermenkephalin_NN ._.
        Our_PRP$ results_NNS indicate_VBP that_IN δ-opioid_JJ receptors_NNS undergo_VBP
        rapid_JJ agonist-regulated_JJ endocytosis_NNS which_WDT is_VBZ similar_JJ to_TO
        that_DT exhibited_VBN by_IN a_DT variety_NN of_IN peptide_NN hormones_NNS and_CC growth_NN
        factors_NNS (_( 24_CD ,_, 25_CD )_) as_RB well_RB as_IN certain_JJ G_NNP protein-coupled_JJ
        receptors_NNS ,_, like_IN β-adrenergic_JJ receptors_NNS (_( 4_LS )_) ,_, neurotensin_NN
        receptors_NNS (_( 26_CD )_) ,_, or_CC substance_NN P_NN receptors_NNS (_( 27_CD )_) ._. In_IN
        adrenergic_JJ receptors_NNS ,_, which_WDT have_VBP been_VBN characterized_VBN in_IN
        detail_NN ,_, rapid_JJ endocytosis_NNS appears_VBZ to_TO be_VB required_VBN for_IN
        resensitization_NN of_IN receptors_NNS following_VBG agonist-induced_JJ
        phosphorylation_NN (_( 28_CD )_) ._. For_IN opioid_NN receptors_NNS ,_, the_DT fate_NN of_IN
        the_DT internalized_JJ receptors_NNS is_VBZ still_RB uncertain_JJ ._. 
        In_IN vivo_NN studies_NNS have_VBP shown_VBN that_DT [_NN 3_CD H_NNP ]_NN
        lofentanyl_NN ,_, a_DT mu_NN agonist_NN ,_, is_VBZ internalized_JJ in_IN axon_NN terminals_NNS
        of_IN rat_NN vagus_JJ nerve_NN and_CC transported_VBN retrogradely_RB in_IN the_DT
        nodose_NN ganglion_NN (_( 29_CD )_) ._. A_DT more_RBR recent_JJ study_NN carried_VBD out_IN in_IN
        rat_NN spinal_JJ cord_NN slices_NNS found_VBD a_DT possible_JJ internalization_NN of_IN
        μ-opioid_JJ receptor_NN after_IN stimulation_NN by_IN DAMGO_NNP (_( 30_CD )_) ._. 
        In_IN vitro_NN studies_NNS carried_VBD out_IN on_IN
        NG_NNP 108_CD -_: 15_CD ,_, a_DT neurohybrid_NN cell_NN expressing_VBG δ-opioid_JJ receptors_NNS ,_,
        showed_VBD internalization_NN after_IN the_DT application_NN of_IN opioid_NN
        agonists_NNS in_IN bath_NN medium_NN ,_, like_IN DADLE_NNP or_CC etorphin_NN (_( 9_CD ,_, 31_CD )_) ._.
        The_DT internalized_JJ receptors_NNS are_VBP then_RB compartmentalized_JJ in_IN
        particular_JJ into_IN lysosomes_NNS and_CC Golgi_NNP apparatus_NN (_( 32_CD )_) ._. More_RBR
        recently_RB ,_, 
        in_IN vitro_NN studies_NNS carried_VBD out_IN on_IN
        δ-opioid_JJ receptors_NNS ,_, showed_VBD that_IN following_VBG a_DT rapid_JJ
        internalization_NN in_IN response_NN to_TO an_DT agonist_NN stimulation_NN ,_, the_DT
        endocytosed_JJ receptors_NNS were_VBD recycled_VBN back_RB to_TO the_DT plasma_NN
        membrane_NN (_( 33_CD )_) ._. It_PRP seems_VBZ that_IN the_DT internalization_NN /_NN recycling_NN
        process_NN is_VBZ a_DT necessary_JJ step_NN in_IN the_DT resensitization_NN of_IN the_DT
        receptor_NN ._. 
        In_IN vivo_NN ,_, due_JJ to_TO the_DT current_JJ
        experimental_JJ conditions_NNS ,_, the_DT fate_NN of_IN internalized_JJ receptors_NNS
        remains_VBZ to_TO be_VB examined_VBN ._.
        Our_PRP$ findings_NNS demonstrate_VBP that_DT dermenkephalin_NN ,_, after_IN 
        in_IN vivo_NN administration_NN ,_, can_MD induce_VB an_DT
        internalization_NN of_IN the_DT δ-opioid_JJ receptor_NN at_IN the_DT level_NN of_IN
        the_DT spinal_JJ cord_NN ._. The_DT effect_NN of_IN the_DT reduction_NN of_IN receptor_NN
        number_NN at_IN the_DT plasma_NN membrane_NN might_MD be_VB a_DT rapid_JJ decrease_NN of_IN
        the_DT physiological_JJ response_NN to_TO the_DT stimulus_NN ._. These_DT results_NNS
        bring_VBP an_DT important_JJ confirmation_NN that_IN data_NNS obtained_VBN in_IN an_DT 
        in_IN vitro_NN system_NN for_IN G_NNP protein-coupled_JJ
        receptor_NN internalization_NN (_( 3_LS )_) are_VBP relevant_JJ to_TO the_DT CNS_NNP 
        in_IN vivo_NN ._. The_DT consequences_NNS on_IN
        receptor_NN expression_NN (_( recycling_NN and_CC /_NN or_CC degradation_NN )_) remain_VB
        to_TO be_VB established_VBN ._.
      
      
        Materials_NNS and_CC methods_NNS
        Experiments_NNS were_VBD performed_VBN on_IN twelve_CD male_JJ 200_CD -_: 300_CD gm_NN
        Wistar_NNP rats_NNS ,_, housed_VBN in_IN controlled_VBN environmental_JJ conditions_NNS
        (_( 22_CD ±_NN 1_CD °_NN C_NNP ,_, 12_CD h_NN alternate_JJ light-dark_JJ cycles_NNS ,_, food_NN and_CC water_NN
        
        ad_NN libitum_NN )_) for_IN at_IN least_JJS one_CD week_NN
        before_IN being_VBG used_VBN for_IN the_DT experiments_NNS ._. Three_CD groups_NNS of_IN four_CD
        animals_NNS were_VBD used_VBN :_: two_CD groups_NNS received_VBD dermenkephalin_NN and_CC
        one_CD control_NN group_NN received_VBD 0_CD ._. 9_CD %_NN NaCl_NNP ._. Two_CD additional_JJ rats_NNS
        received_VBD a_DT cocktail_NN of_IN peptidase_NN inhibitors_NNS (_( i_NNP ._. e_SYM ._. without_IN
        dermenkephalin_NN )_) in_IN NaCl_NNP for_IN 15_CD and_CC 30_CD minutes_NNS to_TO check_VB if_IN
        the_DT endogenous_JJ enkephalins_NNS protected_VBN by_IN kelatorphan_NN and_CC
        thiorphan_NN could_MD ,_, by_IN themselves_PRP ,_, induce_VB receptor_NN
        internalization_NN ._.
        Under_IN deep_JJ urethane_NN anesthesia_NN (_( 1_CD ._. 5_LS g_SYM kg_NN -_: 1_CD body_NN weight_NN )_) ,_,
        the_DT cisterna_NN magna_NN was_VBD opened_VBN ._. A_DT catheter_NN was_VBD inserted_VBN
        intrathecally_RB in_IN the_DT subarachnoid_NN space_NN to_TO the_DT level_NN of_IN the_DT
        fourth_JJ or_CC fifth_JJ cervical_JJ segment_NN ._. The_DT two_CD experimental_JJ
        groups_NNS received_VBD intrathecally_RB 10_CD μl_NN of_IN a_DT mixture_NN containing_VBG
        10_CD μM_NN of_IN thiorphan_NN and_CC 20_CD μM_NN of_IN kelatorphan_NN (_( to_TO delay_VB the_DT
        degradation_NN of_IN the_DT peptide_NN ligand_NN )_) and_CC 10_CD μM_NN of_IN
        dermenkephalin_NN (_( Tyr-_NNP D-M_NNP et-_NN Phe-_NNP His-_NNP Leu-_NNP Met-_NNP Asp-_NNP NH_NNP 
        2_CD ,_, Sigma_NNP ,_, a_DT selective_JJ δ_NN agonist_NN (_( 14_CD ,_,
        34_CD )_) )_) ,_, in_IN 0_CD ._. 9_CD %_NN NaCl_NNP ._. Control_NN rats_NNS received_VBD 10_CD μl_NN 0_CD ._. 9_CD %_NN NaCl_NNP ._.
        A_DT few_JJ minutes_NNS after_IN injection_NN ,_, the_DT catheter_NN was_VBD gently_RB
        removed_VBN ._. Fifteen_CD or_CC 30_CD minutes_NNS after_IN the_DT intrathecal_NN
        injection_NN ,_, the_DT rats_NNS were_VBD perfused_JJ with_IN 100_CD ml_NN of_IN 0_CD ._. 9_CD %_NN NaCl_NNP
        containing_VBG 0_CD ._. 1_CD %_NN sodium_NN nitrite_NN as_IN washing_VBG solution_NN followed_VBN
        by_IN about_IN 800_CD ml_NN of_IN fixative_JJ containing_VBG 4_CD %_NN paraformaldehyde_NN
        in_IN Sörensen_NNP buffer_NN (_( 0_CD ._. 1_LS M_NNP ,_, pH_NN 7_CD ._. 4_LS )_) ._. The_DT procedure_NN for_IN the_DT
        ultrastructural_NN localization_NN of_IN δ-opioid_JJ receptors_NNS was_VBD
        carried_VBN out_IN as_RB previously_RB described_VBD (_( 12_CD )_) ._. Briefly_NNP ,_,
        transverse_NN sections_NNS of_IN cervical_JJ and_CC thoracic_JJ cord_NN (_( 50_CD μm_NN )_)
        were_VBD cut_VBN with_IN a_DT vibratome_NN ._. A_DT rat_NN monoclonal_NN anti-idiotypic_JJ
        antibody_NN (_( anti-_NN Id_NN mAb_NN ;_: 8_CD mg_NN /_NN ml_NN ;_: )_) ,_, generated_VBN against_IN an_DT
        anti-_NN D-A_NNP la_FW 2_CD -_: D-L_NNP eu_NN 5_CD -_: Enkephalin_NNP (_( DADLE_NNP )_) antibody_NN and_CC
        displaying_VBG affinity_NN for_IN δ-opioid_JJ receptors_NNS (_( 10_CD ,_, 12_CD )_) ,_, was_VBD
        used_VBN as_IN the_DT primary_JJ antibody_NN ._. The_DT sections_NNS were_VBD incubated_JJ
        with_IN the_DT anti-_NN Id_NN mAb_NN at_IN 1_CD :_: 500_CD dilution_NN in_IN Sörensen_NNP buffer_NN
        containing_VBG 3_CD %_NN normal_JJ sheep_NN serum_NN overnight_JJ at_IN 4_CD °_NN C_NNP ,_, followed_VBN
        by_IN an_DT incubation_NN with_IN biotinylated_JJ anti-rat_JJ IgG_NNP (_( 1_CD :_: 200_CD
        dilution_NN for_IN 1_CD hour_NN ,_, Vector_NNP Laboratories_NNPS )_) and_CC then_RB with_IN
        avidin-biotin-horseradish_JJ peroxidase_NN complex_JJ (_( ABC-HRP_NNP ,_,
        Vector_NNP Laboratories_NNPS )_) for_IN 1_CD hour_NN ._. After_IN rinsing_VBG ,_, the_DT
        peroxidase_NN activity_NN was_VBD revealed_VBN with_IN 3_CD ,_, 3_CD '_POS -_: diaminobenzidine_NN
        (_( Sigma_NNP ,_, 15_CD mg_NN /_NN 50_CD ml_NN Tris-_NNP HCl_NNP in_IN the_DT presence_NN of_IN 0_CD ._. 01_CD %_NN
        hydrogen_NN peroxide_NN )_) ._. Finally_RB ,_, the_DT sections_NNS were_VBD postfixed_JJ
        with_IN 2_CD %_NN osmium_NN tetroxide_NN ,_, dehydrated_JJ and_CC flat_RB embedded_VBN in_IN
        araldite_NN ._. Semithin_NNP and_CC ultrathin_NN sections_NNS were_VBD cut_VBN and_CC
        contrasted_VBN with_IN lead_NN citrate_NN and_CC examined_VBD with_IN a_DT JEOL_NNP X_NNP 100_CD
        electron_NN microscope_NN ._.
      
    
  
